EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,124,147 | -25.0% | 2,660,142 | -34.4% | 0.07% | -21.6% |
| Q2 2023 | $77,512,088 | -16.0% | 4,056,102 | -14.7% | 0.09% | -17.8% |
| Q1 2023 | $92,250,529 | +50.2% | 4,752,734 | +24.1% | 0.11% | +46.6% |
| Q4 2022 | $61,405,261 | +7.4% | 3,828,545 | +5.0% | 0.07% | -1.4% |
| Q3 2022 | $57,173,000 | -15.8% | 3,646,246 | +11.8% | 0.07% | -11.9% |
| Q2 2022 | $67,919,000 | -15.9% | 3,262,192 | -8.4% | 0.08% | +1.2% |
| Q1 2022 | $80,759,000 | +62.0% | 3,562,353 | +30.6% | 0.08% | +72.9% |
| Q4 2021 | $49,845,000 | -36.0% | 2,726,732 | -26.0% | 0.05% | -42.9% |
| Q3 2021 | $77,852,000 | +34.8% | 3,682,679 | +16.2% | 0.08% | +35.5% |
| Q2 2021 | $57,736,000 | -27.1% | 3,168,813 | -9.7% | 0.06% | -35.4% |
| Q1 2021 | $79,245,000 | +17.9% | 3,507,974 | +4.7% | 0.10% | +7.9% |
| Q4 2020 | $67,217,000 | -30.7% | 3,349,143 | -15.6% | 0.09% | -42.6% |
| Q3 2020 | $97,032,000 | -5.6% | 3,968,603 | -8.4% | 0.16% | -12.9% |
| Q2 2020 | $102,824,000 | +20.2% | 4,331,238 | -12.8% | 0.18% | -8.2% |
| Q1 2020 | $85,534,000 | +10.4% | 4,967,140 | +12.9% | 0.19% | +47.0% |
| Q4 2019 | $77,497,000 | +8.9% | 4,398,219 | +9.3% | 0.13% | -1.5% |
| Q3 2019 | $71,186,000 | -43.2% | 4,025,206 | -31.4% | 0.13% | -43.2% |
| Q2 2019 | $125,349,000 | -3.0% | 5,865,637 | +8.0% | 0.24% | -8.2% |
| Q1 2019 | $129,292,000 | +18.4% | 5,432,435 | -2.1% | 0.26% | -0.8% |
| Q4 2018 | $109,191,000 | +32.7% | 5,551,138 | +19.5% | 0.26% | +69.3% |
| Q3 2018 | $82,287,000 | +47.1% | 4,643,726 | +78.6% | 0.15% | +31.9% |
| Q2 2018 | $55,942,000 | +189.3% | 2,599,525 | +197.8% | 0.12% | +163.6% |
| Q1 2018 | $19,337,000 | +0.1% | 873,018 | +37.3% | 0.04% | -4.3% |
| Q4 2017 | $19,327,000 | -26.6% | 635,762 | -41.5% | 0.05% | -32.4% |
| Q3 2017 | $26,317,000 | +577.7% | 1,086,135 | +588.9% | 0.07% | +580.0% |
| Q2 2017 | $3,883,000 | +8.7% | 157,660 | -4.4% | 0.01% | 0.0% |
| Q1 2017 | $3,573,000 | +40.3% | 164,903 | -3.4% | 0.01% | +25.0% |
| Q4 2016 | $2,546,000 | -23.8% | 170,750 | -34.7% | 0.01% | -20.0% |
| Q3 2016 | $3,343,000 | +414.3% | 261,374 | +214.2% | 0.01% | +400.0% |
| Q2 2016 | $650,000 | – | 83,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |